PTC Therapeutics, Inc. Repayments of Debt
PTC Therapeutics, Inc. (PTCT) reported Repayments of Debt of $1.67 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2019-08-06
- 2019-06-30: Repayments of Debt 6 month $1.67M.
- 2018-06-30: Repayments of Debt 6 month $0.00.
- 2013-07-31: Repayments of Debt 1 month $2.60M.
| Period end | Repayments of Debt 1 month | Repayments of Debt 6 month |
|---|---|---|
| 2019-06-30 | $1.67M 10-Q · filed 2019-08-06 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-06 | |
| 2013-07-31 | $2.60M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |